These FTSE 100 stocks could be set for big moves in November

Many FTSE 100 stocks are down to report to the market next month. Our writer picks out three he’ll be watching particularly closely.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Middle-aged black male working at home desk

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

As the colder weather draws in, the news flow from some of the biggest UK companies heats up. And this could mean their share prices are set for some big moves in November.

In which direction? Well, that’s open to debate.

Next

Reporting early next month is clothing and home retailer Next (LSE: NXT).

The fact that it scores consistently well on quality metrics suggests the £6bn cap is one of the best retailers in the entire UK market. Unfortunately, this is easily forgotten in a period of market malaise such as the one we’re in. The shares were down 41% year-to-date by the end of Friday.

This isn’t hard to fathom. As a general rule, any company that relies on discretionary spending tends to do badly during recessions. I don’t see Next being the exception here. And if sales have been even worse than anticipated, there could be more pain to come for existing holders. Full-year profit guidance was already reduced by £20m to £840m in September.

On the flip side, even a slightly better-than-expected statement on 2 November could be warmly received by a market desperate for something to smile about.

I’m content to watch rather than buy Next shares for now.

Taylor Wimpey

Top league housebuilder Taylor Wimpey (LSE: TW) delivers its latest update on 9 November. After halving in value in 2022, investors will be hoping for something, anything, to stabilise the share price.

I think they may be disappointed, at least as far as the outlook for trading is concerned. While completions may have been fairly steady over the summer, the recent rise in interest rates is likely to be impacting demand for new homes.

How much of all this is priced in? I suspect a fair bit. The stock already changes hands on a seriously low price-to-earnings (P/E) ratio of five. What’s more, it yields a forecast 11%, at least for now.

That last bit is important. While earnings should cover the payout, I’m wary of relying too much on Taylor Wimpey for generating passive income going forward.

Again, I’m keeping my powder dry until after that statement.

Halma

Last on today’s list of FTSE 100 stocks that I’ll be watching is Halma (LSE: HLMA). Of the three I’ve highlighted today, I’d say this company is the least cyclical. Halma specialises in life-saving technologies across three market areas: Safety, Environment and Health– not the sort of things that employers can afford to ignore thanks to increasing regulation.

Notwithstanding this, 2022 hasn’t been a vintage year for those already holding. The company’s valuation has sunk 35%.

Despite this fall, Halma shares still change hands at a P/E of 29. That’s still high, at least relative to many/most other UK-listed shares. While I do think this premium can be justified to some extent (Halma has an unbroken record of increasing its dividend by 5% or more for the last 43 years!), it’s still not ideal in the current climate. There’s a risk we could see a big move in the price if the half-year numbers on 17 November disappoint.

There is, however, something to be positive about here. Unlike Next, Halma retained its full-year guidance in September. Perhaps the worst is over.

Regardless, I still remain very interested in opening a position here.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK has recommended Halma. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »